Cost-effectiveness modeling from UK indicates that endoscopic eradiction therapy for both low and high-grade dysplasia is cost-effective compared to surveillance.
Long term outcomes from SURF clinical trial of RFA for low grade dysplasia confirms strong benefit in risk of HGD or esophageal adenocarcinoma.
Ireland consortium estimates progression from Barrett's to esophageal adenocarcinoma or high grade dysplasia, finding risks similar to previous studies, but higher risk among confirmed low grade dysplasias.
In this publication, the American Society for Gastrointestinal Endoscopy updated their guidelines for screening/surveillance of BE. ASGE guideline on screening and surveillance of Barrett’sesophagusGastrointest Endosc. 2019 Sep;90(3):335-359.e2.
French investigators observed that modification of a standard bariatric surgery technique resulted in low prevalence of post-surgery GERD symptoms. Obes Surg. 2020 Feb 14 doi: 10.1007/s11695-020-04469-5. The Nissen-Sleeve (N-Sleeve): Results of
Kit Curtius and colleagues from the U.S. and India demonstrate how mathematical modeling of cancer evolution can be used to optimize age at initial screening for Barrett's and esophageal adenocarcinoma. Their research